Published in Hepatology on February 01, 1993
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut (2007) 4.51
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut (1997) 1.09
Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE. J Clin Invest (1997) 1.00
Hepatorenal syndrome. World J Gastroenterol (2012) 0.93
Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis. Korean J Intern Med (2004) 0.92
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol (2014) 0.90
Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci (2003) 0.84
Doppler ultrasound of hepatic and system hemodynamics in patients with alcoholic liver cirrhosis. Dig Dis Sci (2009) 0.84
Updates on Hepato-Renal Syndrome. J Anesth Clin Res (2013) 0.83
Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis. Eur J Clin Pharmacol (2011) 0.81
HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation. Hypertension (2013) 0.81
Abnormal Expression of Urea Transporter Protein in a Rat Model of Hepatorenal Syndrome Induced by Succinylated Gelatin. Med Sci Monit (2015) 0.80
Prostaglandin E1 infusion and functional hepatic flow in control subjects and in patients with cirrhosis. Dig Dis Sci (1999) 0.79
Effect of meal induced splanchnic arterial vasodilatation on renal arterial haemodynamics in normal subjects and patients with cirrhosis. Gut (1998) 0.76
Renal haemodynamics and function following partial portal decompression. HPB (Oxford) (2009) 0.75
Characterization of a murine model of cardiorenal syndrome type 1 by high-resolution Doppler sonography. J Ultrasound (2014) 0.75
Renal dysfunction in patients with chronic liver disease. Electrolyte Blood Press (2009) 0.75
Renal vasoconstriction in cirrhosis. Hepatology (1994) 0.75
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis (2001) 2.76
The tRNA genes punctuate the reading of genetic information in human mitochondrial DNA. Cell (1980) 2.53
Long term effect of alpha interferon in children with chronic hepatitis B. Gut (2000) 2.21
Three-dimensional structure of the tetragonal crystal form of egg-white avidin in its functional complex with biotin at 2.7 A resolution. J Mol Biol (1993) 2.18
Refined crystal structure of ascorbate oxidase at 1.9 A resolution. J Mol Biol (1992) 2.18
Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med (1991) 1.91
Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. J Biol Chem (1988) 1.91
X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligands. J Mol Biol (1989) 1.90
CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. EMBO J (2001) 1.90
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology (1999) 1.74
Crystal structure of D-amino acid oxidase: a case of active site mirror-image convergent evolution with flavocytochrome b2. Proc Natl Acad Sci U S A (1996) 1.68
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology (1996) 1.68
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. Gut (2010) 1.65
Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med (1994) 1.65
Nutrition and survival in patients with liver cirrhosis. Nutrition (2001) 1.60
Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology (1994) 1.54
Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition (1997) 1.54
Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood. Dig Liver Dis (2005) 1.51
Conserved patterns in the Cu,Zn superoxide dismutase family. J Mol Biol (1994) 1.49
A persulfurated cysteine promotes active site reactivity in Azotobacter vinelandii Rhodanese. Biol Chem (2001) 1.47
Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. Hepatology (1996) 1.46
Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club. Ital J Gastroenterol Hepatol (1997) 1.45
Fractionation of mitochondrial RNA from HeLa cells by high-resolution electrophoresis under strongly denaturing conditions. J Mol Biol (1978) 1.44
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. Neurology (2006) 1.42
The crystal structure of a sulfurtransferase from Azotobacter vinelandii highlights the evolutionary relationship between the rhodanese and phosphatase enzyme families. J Mol Biol (2000) 1.40
Hypophosphatemia and renal tubular dysfunction in alcoholics. Are they related to liver function impairment? Gastroenterology (1991) 1.39
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol (1998) 1.39
Mycobacterium tuberculosis hemoglobin N displays a protein tunnel suited for O2 diffusion to the heme. EMBO J (2001) 1.33
Crystal structure of the trigonal form of bovine beta-lactoglobulin and of its complex with retinol at 2.5 A resolution. J Mol Biol (1987) 1.33
A novel two-over-two alpha-helical sandwich fold is characteristic of the truncated hemoglobin family. EMBO J (2000) 1.31
Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology (1999) 1.25
Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol (1996) 1.25
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (2000) 1.24
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood (2001) 1.24
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology (2000) 1.24
Unusual structure of the oxygen-binding site in the dimeric bacterial hemoglobin from Vitreoscilla sp. Structure (1997) 1.23
Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis (2002) 1.18
Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr (1996) 1.16
Kinetic and crystallographic analyses support a sequential-ordered bi bi catalytic mechanism for Escherichia coli glucose-1-phosphate thymidylyltransferase. J Mol Biol (2001) 1.16
Crystal structure of NH3-dependent NAD+ synthetase from Bacillus subtilis. EMBO J (1996) 1.16
The allosteric regulation of pyruvate kinase. FEBS Lett (1996) 1.15
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer (2004) 1.14
Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine. Eur J Pharmacol (1987) 1.13
Active site plasticity in D-amino acid oxidase: a crystallographic analysis. Biochemistry (1997) 1.13
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (2000) 1.13
Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology (1992) 1.10
Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol (2001) 1.10
Structural bases for sulfide recognition in Lucina pectinata hemoglobin I. J Mol Biol (1996) 1.08
Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol (1999) 1.08
Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology (1994) 1.07
New structures of allosteric proteins revealing remarkable conformational changes. Curr Opin Struct Biol (1996) 1.07
Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib. Br J Cancer (2010) 1.06
Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations. Clin Orthop Relat Res (1989) 1.06
Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 A resolution. J Mol Biol (1992) 1.06
Crystal structure of apo-avidin from hen egg-white. J Mol Biol (1994) 1.06
Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon. Gastroenterology (2000) 1.05
Crystal structure of yeast Cu,Zn superoxide dismutase. Crystallographic refinement at 2.5 A resolution. J Mol Biol (1992) 1.05
Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirrhosis. J Hepatol (1997) 1.04
Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation. Eur J Immunol (2000) 1.04
The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology (1996) 1.04
Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci (1991) 1.04
Structure of the sulfide-reactive hemoglobin from the clam Lucina pectinata. Crystallographic analysis at 1.5 A resolution. J Mol Biol (1994) 1.04
Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition. Structure (1995) 1.03
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant (2007) 1.03
Paraumbilical vein patency in cirrhosis: effects on hepatic hemodynamics evaluated by Doppler sonography. Hepatology (1995) 1.03